← 產業報告目錄
mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA, Enzymes, Others), By Application (Vaccine Production, Therapeutics Production, Others), By End-user (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes), By Region, and Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-06頁數 184報告編號 INSIGHTACE-f511c7ae56
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 1.8 Bn as of 2024, the global mRNA Synthesis Raw Materials Market is poised to climb to USD 3.4 Bn by 2034, reflecting a compound annual growth rate of 6.6% over the 2025–2034 period.
The mRNA Synthesis Raw Materials sector involves key industry insights & findings from the report:
Leading pharmaceutical companies new product introductions that improve service quality, rising service standards, and increased facility personaliza. This domain has witnessed pronounced transformation owing to technological breakthroughs and shifting healthcare dynamics.
Market momentum is propelled by mounting need advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global MRNA Synthesis Raw Materials Market Snapshot
Chapter 4. Global MRNA Synthesis Raw Materials Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Global MRNA Synthesis Raw Materials Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
Chapter 5. MRNA Synthesis Raw Materials Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. Market Share by Type, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type:
5.2.1. Capping Agents
5.2.1.1. Cappping Reagents
5.2.1.2. ARCA (Anti-Reverse Cap Analog)
5.2.1.3. Others (Vaccinia Capping Enzyme, etc.)
5.2.2. Nucleotides
5.2.2.1. Modified Nucleic Acids
5.2.2.1.1. N1-methylpseudouridine-triphosphate
5.2.2.1.2. 5-Methylcytidine triphosphate (5mCTP)
5.2.2.1.3. Others
5.2.2.2. Natural Nucleic Acids
5.2.2.2.1. Adenine
5.2.2.2.2. Guanine
5.2.2.2.3. Cytosine
5.2.2.2.4. Uracil
5.2.2.3. Plasmid DNA
5.2.2.4. Enzymes
5.2.2.4.1. T7 RNA Polymerase
5.2.2.4.2. SP6/T3 Polymerase
5.2.2.4.4. RNase Inhibitor
5.2.2.4.5. DNase
5.2.2.4.6. Others
5.2.2.5. Lipids & Formulation Materials
5.2.2.5.1. Ionizable Lipids
5.2.2.5.2. PEG-Lipids
5.2.2.6. Purification & Analytical Materials
Chapter 6. MRNA Synthesis Raw Materials Market Segmentation 2: By Grade Type, Estimates & Trend Analysis
6.1. Market Share by Grade Type, 2024 & 2034
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Grade Type:
6.2.1. Research Grade
6.2.2. GMP Grade
Chapter 7. MRNA Synthesis Raw Materials Market Segmentation 3: By Application, Estimates & Trend Analysis
7.1. Market Share by Application, 2024 & 2034
7.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
7.2.1. Therapeutics Typeion
7.2.2. Vaccine Typeion
7.2.3. Others
Chapter 8. MRNA Synthesis Raw Materials Market Segmentation 4: By End-user, Estimates & Trend Analysis
8.1. Market Share by End-user, 2024 & 2034
8.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-user:
8.2.1. Biotechnology & Pharmaceutical Companies
8.2.2. CMOs & CROs
8.2.3. Research and Academic Institutes
Chapter 9. MRNA Synthesis Raw Materials Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global MRNA Synthesis Raw Materials Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Type, 2021-2034
9.2.3. North America MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Grade Type, 2021-2034
9.2.4. North America MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Application, 2021-2034
9.2.5. North America MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by End-user, 2021-2034
9.3. Europe
9.3.1. Europe MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Type, 2021-2034
9.3.3. Europe MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Grade Type, 2021-2034
9.3.4. Europe MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Application, 2021-2034
9.3.5. Europe MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by End-user, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Type, 2021-2034
9.4.3. Asia Pacific MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Grade Type, 2021-2034
9.4.4. Asia Pacific MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Application, 2021-2034
9.4.5. Asia Pacific MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by End-user, 2021-2034
9.5. Latin America
9.5.1. Latin America MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Type, 2021-2034
9.5.3. Latin America MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Grade Type, 2021-2034
9.5.4. Latin America MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Application, 2021-2034
9.5.5. Latin America MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by End-user, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Type, 2021-2034
9.6.3. Middle East & Africa MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Grade Type, 2021-2034
9.6.4. Middle East & Africa MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by Application, 2021-2034
9.6.5. Middle East & Africa MRNA Synthesis Raw Materials Market Revenue (US$ Mn) Estimates and Forecasts by End-user, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Roche
10.2.1.1. Business Overview
10.2.1.2. Key Type/Service
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Thermo Fisher Scientific Inc
10.2.3. Creative Enzymes
10.2.4. Promega Corporation
10.2.5. Merck
10.2.6. BOC Sciences
10.2.7. Jena Bioscience GmbH
10.2.8. Aldevron
10.2.9. Sichuan Qingmu Pharmaceutical Co., Ltd
10.2.10. TriLink BioTechnologies
10.2.11. Creative Biogene
10.2.12. New England Biolabs
10.2.13. Other Prominent Players
10.2.13.1. Bio-Synthesis Inc.
10.2.13.2. Integrated DNA Technologies (IDT)
10.2.13.3. GenScript Biotech Corporation
10.2.13.4. Yeasen Biotechnology (Shanghai) Co., Ltd.
10.2.13.5. Eurogentec
10.2.13.6. Beijing SBS Genetech Co., Ltd.
10.2.13.7. Lucigen (LGC Biosearch Technologies)
10.2.13.8. BioCat GmbH
10.2.13.9. ATDBio Ltd.
10.2.13.10. Bio Basic Inc.
10.2.13.11. Sartorius AG
10.2.13.12. HONGENE
10.2.13.13. ArcticZymes Technologies
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們